These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 2880608)

  • 1. Beta 2-adrenergic regulation of prostaglandin D2 receptor in rabbit platelets.
    Hanasaki K; Mizuno Y; Ikeda M; Shimonishi M; Yoshimura S; Tomita K; Ichikawa A
    Biochim Biophys Acta; 1987 Feb; 927(2):261-8. PubMed ID: 2880608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of prostaglandin D2 receptors by agonist binding to beta-adrenoceptors in rabbit platelets.
    Ichikawa A; Mizuno Y; Hanasaki K; Yoshimura S; Tomita K
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():671-2. PubMed ID: 3004152
    [No Abstract]   [Full Text] [Related]  

  • 3. Receptor-specific threshold effects of cyclic AMP are involved in the regulation of enzyme release and superoxide production from human neutrophils.
    Lad PM; Goldberg BJ; Smiley PA; Olson CV
    Biochim Biophys Acta; 1985 Aug; 846(2):286-95. PubMed ID: 2411298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor (norepinephrine), P-site (2',5'-dideoxyadenosine), and calcium-mediated inhibition of prostaglandin and forskolin-activated cyclic AMP-generating systems in human platelets.
    Siegl AM; Daly JW
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(3):229-45. PubMed ID: 2991349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The binding of 6-oxo-prostaglandin E1 to platelet prostanoid receptors.
    Jaschonek K; Renn W; Weisenberger H
    Prostaglandins Leukot Med; 1986 Sep; 24(1):79-86. PubMed ID: 3020591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
    Haslam RJ; Davidson MM; Desjardins JV
    Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of the control of renin release by beta-adrenergic receptors.
    Suzuki S; Hashiba K
    Jpn Heart J; 1986 Nov; 27(6):871-80. PubMed ID: 3033346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic adenosine monophosphate production and contractile response induced by beta-adrenoceptor subtypes in rabbit urinary bladder smooth muscle.
    Morita T; Dohkita S; Kondo S; Nishimoto T; Hirano S; Tsuchida S
    Urol Int; 1990; 45(1):10-5. PubMed ID: 1968300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet beta-adrenoceptors.
    Kerry R; Scrutton MC
    Br J Pharmacol; 1983 Jul; 79(3):681-91. PubMed ID: 6140045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets.
    Williams KA; Murphy W; Haslam RJ
    Biochem J; 1987 May; 243(3):667-78. PubMed ID: 2444206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the platelet prostaglandin D2 receptor. Loss of prostaglandin D2 receptors in platelets of patients with myeloproliferative disorders.
    Cooper B; Ahern D
    J Clin Invest; 1979 Aug; 64(2):586-90. PubMed ID: 222813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic AMP induces synthesis of prostaglandin E1 in platelets.
    Dayal V; Colman RW; Prakash O; Bose AK; Sinha AK
    Biochim Biophys Acta; 1983 Sep; 759(3):129-36. PubMed ID: 6309248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refractoriness of platelets to prostaglandins after infusion in rabbits.
    Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
    J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
    Ohkubo S; Nakahata N; Ohizumi Y
    Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forskolin potentiates isoproterenol induced beta adrenoceptor desensitization in intact human lymphocytes.
    Yu JL; Hui KK
    Res Commun Chem Pathol Pharmacol; 1988 Jul; 61(1):3-16. PubMed ID: 2845534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct mechanisms of forskolin-stimulated cyclic AMP accumulation and forskolin-potentiated hormone responses in C6-2B cells.
    Barovsky K; Pedone C; Brooker G
    Mol Pharmacol; 1984 Mar; 25(2):256-60. PubMed ID: 6321948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation by cyclic AMP of beta adrenergic receptor-stimulated prostacyclin synthesis in rabbit ventricular myocytes.
    Ruan Y; Kan H; Malik KU
    J Pharmacol Exp Ther; 1996 Aug; 278(2):482-9. PubMed ID: 8768695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-adrenoceptor antagonists and human platelets: relationship of effects to lipid solubility.
    Kerry R; Scrutton MC; Wallis RB
    Biochem Pharmacol; 1984 Aug; 33(16):2615-22. PubMed ID: 6147145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antagonism of prostaglandins I2, E1 and D2 by prostaglandin E2 in human platelets.
    Bonne C; Martin B; Watada M; Regnault F
    Thromb Res; 1981 Jan 1-15; 21(1-2):13-22. PubMed ID: 6262942
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH; Haslam RJ
    Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.